PMID- 23055271 OWN - NLM STAT- MEDLINE DCOM- 20130225 LR - 20221207 IS - 1531-8249 (Electronic) IS - 0364-5134 (Print) IS - 0364-5134 (Linking) VI - 72 IP - 6 DP - 2012 Dec TI - Risk for myasthenia gravis maps to a (151) Pro-->Ala change in TNIP1 and to human leukocyte antigen-B*08. PG - 927-35 LID - 10.1002/ana.23691 [doi] AB - OBJECTIVE: The objective of this study is to comprehensively define the genetic basis of early onset myasthenia gravis (EOMG). METHODS: We have carried out a 2-stage genome-wide association study on a total of 649 North European EOMG patients. Cases were matched 1:4 with controls of European ancestry. We performed imputation and conditional analyses across the major histocompatibility complex, as well as in the top regions of association outside the human leukocyte antigen (HLA) region. RESULTS: We observed the strongest association in the HLA class I region at rs7750641 (p = 1.2 x 10(-92) ; odds ratio [OR], 6.25). By imputation and conditional analyses, HLA-B*08 proves to be the major associated allele (p = 2.87 x 10(-113) ; OR, 6.41). In addition to the expected association with PTPN22 (rs2476601; OR, 1.71; p = 8.2 x 10(-10) ), an imputed coding variant (rs2233290) at position 151 (Pro-->Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR, 1.91; p = 3.2 x 10(-10) ). INTERPRETATION: The association at TNIP1 in EOMG implies disease mechanisms involving ubiquitin-dependent dysregulation of NF-kappaB signaling. The localization of the major HLA signal to the HLA-B*08 allele suggests that CD8(+) T cells may play a key role in disease initiation or pathogenesis. CI - Copyright (c) 2012 American Neurological Association. FAU - Gregersen, Peter K AU - Gregersen PK AD - Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY 11030, USA. peterg@nshs.edu FAU - Kosoy, Roman AU - Kosoy R FAU - Lee, Annette T AU - Lee AT FAU - Lamb, Janine AU - Lamb J FAU - Sussman, Jon AU - Sussman J FAU - McKee, David AU - McKee D FAU - Simpfendorfer, Kim R AU - Simpfendorfer KR FAU - Pirskanen-Matell, Ritva AU - Pirskanen-Matell R FAU - Piehl, Frederik AU - Piehl F FAU - Pan-Hammarstrom, Qiang AU - Pan-Hammarstrom Q FAU - Verschuuren, Jan J G M AU - Verschuuren JJ FAU - Titulaer, Maarten J AU - Titulaer MJ FAU - Niks, Erik H AU - Niks EH FAU - Marx, Alexander AU - Marx A FAU - Strobel, Philipp AU - Strobel P FAU - Tackenberg, Bjorn AU - Tackenberg B FAU - Putz, Michael AU - Putz M FAU - Maniaol, Angelina AU - Maniaol A FAU - Elsais, Ahmed AU - Elsais A FAU - Tallaksen, Chantal AU - Tallaksen C FAU - Harbo, Hanne F AU - Harbo HF FAU - Lie, Benedicte A AU - Lie BA FAU - Raychaudhuri, Soumya AU - Raychaudhuri S FAU - de Bakker, Paul I W AU - de Bakker PI FAU - Melms, Arthur AU - Melms A FAU - Garchon, Henri-Jean AU - Garchon HJ FAU - Willcox, Nicholas AU - Willcox N FAU - Hammarstrom, Lennart AU - Hammarstrom L FAU - Seldin, Michael F AU - Seldin MF LA - eng GR - R01 AI068759/AI/NIAID NIH HHS/United States GR - R01 AR062886/AR/NIAMS NIH HHS/United States GR - MRC_/Medical Research Council/United Kingdom GR - R01-AI-68759/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20121010 PL - United States TA - Ann Neurol JT - Annals of neurology JID - 7707449 RN - 0 (DNA-Binding Proteins) RN - 0 (HLA-B8 Antigen) RN - 0 (TNIP1 protein, human) RN - 9DLQ4CIU6V (Proline) RN - OF5P57N2ZX (Alanine) SB - IM MH - Adult MH - Age of Onset MH - Alanine/*genetics MH - Case-Control Studies MH - DNA-Binding Proteins/*genetics MH - Europe MH - Female MH - Gene Frequency MH - *Genetic Predisposition to Disease MH - Genome-Wide Association Study MH - Genotype MH - HLA-B8 Antigen/*genetics MH - Humans MH - Male MH - Meta-Analysis as Topic MH - Myasthenia Gravis/*genetics MH - Polymorphism, Single Nucleotide/*genetics MH - Proline/*genetics MH - White People/genetics MH - Young Adult PMC - PMC3535539 MID - NIHMS392966 EDAT- 2012/10/12 06:00 MHDA- 2013/02/26 06:00 PMCR- 2013/12/01 CRDT- 2012/10/12 06:00 PHST- 2012/02/22 00:00 [received] PHST- 2012/05/18 00:00 [revised] PHST- 2012/06/13 00:00 [accepted] PHST- 2012/10/12 06:00 [entrez] PHST- 2012/10/12 06:00 [pubmed] PHST- 2013/02/26 06:00 [medline] PHST- 2013/12/01 00:00 [pmc-release] AID - 10.1002/ana.23691 [doi] PST - ppublish SO - Ann Neurol. 2012 Dec;72(6):927-35. doi: 10.1002/ana.23691. Epub 2012 Oct 10.